Correction: Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action
Unknown · 2025
Read Correction: Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action by Unknown (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12742120.txt.
Description
A correction notice fixes two vaccine prices in a study of how China finances new additions to its national immunisation programme. In the China 2024 column of the prices table, the BCG vaccine should read US$0.69 per dose instead of US$3.44. The diphtheria-tetanus vaccine should read US$0.09 instead of US$0.36. Both errors stemmed from a miscalculation. The notice states that the mistakes are confined to that table and leave the study's main findings, analyses, and conclusions untouched.
Catalog record
| CREATOR | Unknown |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |